Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQVS9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,985
Award facts
- Contract value 100% obligated
- $4,985.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,985.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the delivery of BOTOX 200 Unit Vials. The contract type is firm fixed price with an ultimate completion date of February 26, 2026. The performance location is Park Ridge, IL, and no set-aside designation was used in this competitive award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded in November 2025 with a $500 million ceiling value and a performance period extending through December 31, 2036.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Department of Defense's military healthcare supply chain, distributing a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, and medical consumables to federal agencies worldwide. As one of multiple regional prime vendors under the broader $30.3 billion PPV-G GEN V acquisition strategy, the company has demonstrated consistent contract performance across numerous delivery orders since October 2025. The company's established position as a trusted federal pharmaceutical supplier, combined with its small business status, enables it to compete effectively in government procurement while supporting the diverse and specialized pharmaceutical requirements of the Department of Defense healthcare system globally.
Quick answers
Who was awarded contract SPE2DR26FQVS9?
SPE2DR26FQVS9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FQVS9 worth?
The government has obligated $4,985 on SPE2DR26FQVS9.
Is contract SPE2DR26FQVS9 an order under another contract?
Yes. SPE2DR26FQVS9 is a delivery order under SPE2DR25D9247, an indefinite delivery contract.
Was contract SPE2DR26FQVS9 competed?
The extent of competition for SPE2DR26FQVS9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award